Post-earnings recap
Reported
Thu, Apr 23, 2015
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Edwards Lifesciences reported earnings that exceeded expectations on EPS, which contributed to a slight increase in stock price. However, without revenue figures or management commentary, it's difficult to assess the overall performance and future outlook. Investors may be cautiously optimistic given the EPS beat.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.12 | N/A | +7.49% |
| Revenue | N/A | N/A | N/A |
No transcript is on record for this earnings call, so the analysis is based solely on numerical results.